NATHAN FOWLER to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications NATHAN FOWLER has written about In Situ Hybridization, Fluorescence.
Connection Strength
0.032
-
Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia: A Nonrandomized Phase 2 Trial. JAMA Oncol. 2021 Aug 01; 7(8):1213-1219.
Score: 0.032